Absci Corp ABSI

$8.74 -0.36 (-3.96%)

Valuation

Market cap
1,561,687,000
Revenue TTM
$2,800,000
Net income TTM
$-115,180,000
PE ratio
0.00
Forward PE
—
Profit margin
-4,113.57%
Debt to equity
0.00

Trading

Volume
3,557,100
Avg volume
3,543,300
Day's range
$8.62 – $9.12
Shares out
171,614,000
Stochastic %K
4%
Beta
2.27
Analysts
Strong Sell
Price target
$14.50

Price

Company profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-...

Show more

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Industry
Biotechnology
Sector
Healthcare
Phone
360 949 1041
Website
https://www.absci.com
Address
18105 SE Mill Plain Boulevard, Vancouver, United States

Latest news

Stocktwits

8Cap Oct 14, 2:32 PM
$ABSI 8.88?!
1 replies
NewsTrader_perform4nce Oct 14, 6:41 AM
BREAKING: Huge deal for $GENB Generate Biomedicines and Zealand Pharma: Sign AI-Driven Obesity Drug Partnership Worth Up to Nearly $1.2 Billion in Milestones GENB could be a 100x stock in my view $MRNA $ABSI $TEM $ABCL
1 replies
7m3835d3 Oct 13, 12:10 PM
$ABSI https://investors.absci.com/news-releases/news-release-details/absci-report-business-updates-and-third-quarter-2026-financial
0 replies
flam70 Oct 12, 12:44 PM
$ABSI
0 replies
7m3835d3 Oct 10, 2:46 PM
$ABSI
1 replies
topstockalerts Oct 9, 10:04 PM
$ABSI feels stronger than it has any right to be
2 replies
JFDI Oct 9, 6:05 PM
$ABSI cookin today off the 50d
0 replies
LabPsycho Oct 9, 4:47 PM
$ABSI @CRMDiamondhands Why though? (the +/- 8-10% swings -multiple times)....hmmm?
2 replies